Putri Annisa Melia Sari

Comparable Effects of Ticagrelor and Clopidogrel Based on Platelet Aggregation Test in Patients with Acute Coronary Syndrome

Ticagrelor and clopidogrel are P2Y₁₂ receptor inhibitors commonly administered as part of dual antiplatelet therapy in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Although ticagrelor demonstrates a more rapid onset of action and stronger platelet inhibition than clop...